Let’s review the therapeutics.
KoolBeens, a surge is coming. May we come out of it least damaged. Still, we need to know what are the options and the best ways to reduce our risk. Let’s review. A major set of content is collected by John Snider. Shout out to John for his miticulous work.
Here is How To Plan For Omicron
The Omicron surge in the USA is going to be scary albeit short lived. Please be ready to understand possible options for you and your loved ones. Make sure you are able to discuss these with your doctor.
URL list from Monday, Jan. 17 2022
DrBeen: Continuing Medical Education Online | USMLE Prep | CME and CE marketplace | Nurse Practitioner and Physician Assistant Training Programs | Medical Student Training
FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR PAXLOVID
FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR MOLNUPIRAVIR
About REGEN-COV Treatment for COVID-19
Fact Sheet For Health Care Providers Emergency Use Authorization (Eua) Of Bamlanivimab
Fact Sheet For Health Care Providers Emergency Use Authorization (Eua) Of Bamlanivimab And Etesevimab 12222021
GSK Sotrovimab Fact Sheet for HCP 12222021
Casirivimab and Imdevimab
Efficacy of Inhaled Ciclesonide for Outpatient Treatment of Adolescents and Adults With Symptomatic COVID-19: A Randomized Clinical Trial | Adolescent Medicine | JAMA Internal Medicine | JAMA Network
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial – The Lancet
Effect of dihydromyricetin on SARS-CoV-2 viral replication and pulmonary inflammation and fibrosis – PubMed
Melatonin interferes with COVID-19 at several distinct ROS-related steps – ScienceDirect
Universally available herbal teas based on sage and perilla elicit potent antiviral activity against SARS-CoV-2 in vitro | bioRxiv
Full article: Low-dose aspirin for early COVID-19: does the early bird catch the worm?
Pathogens | Free Full-Text | Highly Specific Sigma Receptor Ligands Exhibit Anti-Viral Properties in SARS-CoV-2 Infected Cells | HTML
COVID-19 Clinical Trials | Temple Health
Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting – Full Text View – ClinicalTrials.gov
A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness – Full Text View – ClinicalTrials.gov
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial – The Lancet Global Health
Nation’s first ivermectin clinical trial now 50 percent enrolled | Medical School – University of Minnesota
Home | COVID-OUT: Outpatient Treatment for SARS-CoV-2 Infection, a Factorial Randomized Trial
Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19 – Full Text View – ClinicalTrials.gov
Effect of forest bathing trips on human immune function – PMC
The effect of herbal remedies on the production of human inflammatory and anti-inflammatory cytokines – PubMed
Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B 12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19) – PubMed
Advice for patients with new-onset anosmia during COVID-19 pandemic.pdf